On August 29, 2018 Audentes Therapeutics, Inc. (Nasdaq : BOLD ), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, reported that it will participate in the following investor conferences in September (Press release, Audentes Therapeutics, AUG 29, 2018, View Source [SID1234529130]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 13th Annual Biotech ConferenceMatthew R. Patterson, Chief Executive OfficerFormat: 1×1 Investor MeetingsWednesday, September 5, 2018Boston, Massachusetts

Morgan Stanley 16th Annual Global Healthcare Conference Natalie Holles, President and Chief Operating

OfficerFormat: Fireside ChatWednesday, September 12, 2018, at 8:10am ETNew York, New York
To access a live webcast of the Morgan Stanley Global Healthcare Conference fireside chat, please visit the Events & Presentations page within the Investors + Media section of the Audentes website. A replay of the live webcast will be available on the Audentes website for approximately 30 days following the conference.